[Federal Register Volume 67, Number 69 (Wednesday, April 10, 2002)]
[Notices]
[Page 17469]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 02-8662]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Registration

    By Notice dated October 2, 2001, and published in the Federal 
Register on October 11, 2001, (66 FR 51970), Norac Company, Inc., 405 
S. Motor Avenue, Azusa, California 91702, made application by renewal 
to the Drug Enforcement Administration (DEA) to be registered as a bulk 
manufacturer of tetrahydrocannabinols (7370), a basic class of 
controlled substance listed in Schedule I.
    The firm plans to manufacture tetrahydrocannabinols (THC) for use 
in treatment of AIDS wasting syndrome and as an antiemetic.
    No comments or objections have been received. DEA has considered 
the factors in Title 21, United States Code, section 823(a) and 
determined that the registration of Norac Company, Inc. to manufacture 
tetrahydrocannabinols is consistent with the public interest at this 
time. DEA has investigated Norac Company, Inc. on a regular basis to 
ensure that the company's continued registration is consistent with the 
public interest. These investigations have included inspection and 
testing of the company's physical security systems, audits of the 
company's records, verification of the company's compliance with state 
and local laws, and a review of the company's background and history. 
Therefore, pursuant to 21 U.S.C. 823 and 28 CFR 0.100 and 0.104, the 
Deputy Assistant Administrator, Office of Diversion Control, hereby 
orders that the application submitted by the above firm for 
registration as a bulk manufacturer of the basic class of controlled 
substance listed above is granted.

    Dated: March 27, 2002.
Laura M. Nagel,
deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 02-8662 Filed 4-9-02; 8:45 am]
BILLING CODE 4410-04-M